The challenges and opportunities in using real-world data to drive advances in healthcare in East Asia: expert panel recommendations
Authors:
Open Access
- 11 July 2022
- journal article
- review article
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 38 (9) , 1543-1551
Abstract
To provide recommendations for overcoming the challenges associated with the generation and use of real-world evidence (RWE) in regulatory approvals, health technology assessments (HTAs), and reimb...Keywords
This publication has 29 references indexed in Scilit:
- Evaluating the Use of Nonrandomized Real‐World Data Analyses for Regulatory Decision MakingClinical Pharmacology & Therapeutics, 2019
- Harnessing the Power of Real‐World Evidence (RWE): A Checklist to Ensure Regulatory‐Grade Data QualityClinical Pharmacology & Therapeutics, 2017
- Series: Pragmatic trials and real world evidence: Paper 6. Outcome measures in the real worldJournal of Clinical Epidemiology, 2017
- Good practices for real‐world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR‐ISPE Special Task Force on real‐world evidence in health care decision makingPharmacoepidemiology and Drug Safety, 2017
- What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder InterviewsValue in Health, 2017
- Tissue-Agnostic Drug DevelopmentAmerican Society of Clinical Oncology Educational Book, 2017
- Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA AgenciesValue in Health, 2017
- Coordination of care in the Chinese health care systems: a gap analysis of service delivery from a provider perspectiveBMC Health Services Research, 2016
- The GRACE Checklist for Rating the Quality of Observational Studies of Comparative Effectiveness: A Tale of Hope and CautionJournal of Managed Care Pharmacy, 2014
- Caveats for the Use of Operational Electronic Health Record Data in Comparative Effectiveness ResearchMedical Care, 2013